Company
Yellowstone Biosciences
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Yellowstone is pioneering soluble T-cell receptor (TCR)-based therapies to unlock a new class of cancer therapeutics.
Loading relationship preview